Current Perspectives on Durable Ventricular Assist Devices
DOI:
https://doi.org/10.59958/hsf.7975Abstract
No abstract present.
References
Scheuer SE, Jansz PC, Macdonald PS. Heart transplantation following donation after circulatory death: Expanding the donor pool. The Journal of Heart and Lung Transplantation: the Official Publication of the International Society for Heart Transplantation. 2021; 40: 882–889.
Kothari P. Ex-Vivo Preservation of Heart Allografts-An Overview of the Current State. Journal of Cardiovascular Development and Disease. 2023; 10: 105.
Griffith BP, Goerlich CE, Singh AK, Rothblatt M, Lau CL, Shah A, et al. Genetically Modified Porcine-to-Human Cardiac Xenotransplantation. The New England Journal of Medicine. 2022; 387: 35–44.
Mohiuddin MM, Singh AK, Scobie L, Goerlich CE, Grazioli A, Saharia K, et al. Graft dysfunction in compassionate use of genetically engineered pig-to-human cardiac xenotransplantation: a case report. Lancet (London, England). 2023; 402: 397–410.
Kirschner M, Topkara VK, Sun J, Kurlansky P, Kaku Y, Naka Y, et al. Comparing 3-year survival and readmissions between HeartMate 3 and heart transplant as primary treatment for advanced heart failure. The Journal of Thoracic and Cardiovascular Surgery. 2023. (online ahead of print)
Dunlay SM, Roger VL, Killian JM, Weston SA, Schulte PJ, Subramaniam AV, et al. Advanced Heart Failure Epidemiology and Outcomes: A Population-Based Study. JACC. Heart Failure. 2021; 9: 722–732.
Mehra MR, Uriel N, Naka Y, Cleveland JC, Jr, Yuzefpolskaya M, Salerno CT, et al. A Fully Magnetically Levitated Left Ventricular Assist Device - Final Report. The New England Journal of Medicine. 2019; 380: 1618–1627.
Jakus N, Brugts JJ, Claggett B, Timmermans P, Pouleur AC, Rubiś P, et al. Improved survival of left ventricular assist device carriers in Europe according to implantation eras: results from the PCHF-VAD registry. European Journal of Heart Failure. 2022; 24: 1305–1315.
Mehra MR, Netuka I, Uriel N, Katz JN, Pagani FD, Jorde UP, et al. Aspirin and Hemocompatibility Events With a Left Ventricular Assist Device in Advanced Heart Failure: The ARIES-HM3 Randomized Clinical Trial. JAMA. 2023; 330: 2171–2181.
Reid G, Mork C, Gahl B, Appenzeller-Herzog C, von Segesser LK, Eckstein F, et al. Outcome of right ventricular assist device implantation following left ventricular assist device implantation: Systematic review and meta-analysis. Perfusion. 2022; 37: 773–784.
Lavee J, Mulzer J, Krabatsch T, Marasco S, McGiffin D, Garbade J, et al. An international multicenter experience of biventricular support with HeartMate 3 ventricular assist systems. The Journal of Heart and Lung Transplantation: the Official Publication of the International Society for Heart Transplantation. 2018; 37: 1399–1402.
Gasparovic H, Milicic D, Krželj K, Paar MH, Kopjar T, Jakus N, et al. HeartMate 3 biventricular support exceeding 4.5 years. ESC Heart Failure. 2023; 10: 2094–2098.
Inglis SS, Suh GA, Razonable RR, Schettle SD, Spencer PJ, Villavicencio MA, et al. Infections in Patients With Left Ventricular Assist Devices: Current State and Future Perspectives. ASAIO Journal (American Society for Artificial Internal Organs: 1992). 2023; 69: 633–641.
Eckmann C, Sunderkötter C, Becker K, Grabein B, Hagel S, Hanses F, et al. Left ventricular assist device-associated driveline infections as a specific form of complicated skin and soft tissue infection/acute bacterial skin and skin structure infection - issues and therapeutic options. Current Opinion in Infectious Diseases. 2024; 37: 95–104.
Saeed D, Grinstein J, Kremer J, Cowger JA. Aortic insufficiency in the patient on contemporary durable left ventricular assist device support: A state-of-the-art review on preoperative and postoperative assessment and management. The Journal of Heart and Lung Transplantation: the Official Publication of the International Society for Heart Transplantation. 2024. (online ahead of print)
Gasparovic H, Kopjar T, Saeed D, Cikes M, Svetina L, Petricevic M, et al. De Novo Aortic Regurgitation After Continuous-Flow Left Ventricular Assist Device Implantation. The Annals of Thoracic Surgery. 2017; 104: 704–711.
Gasparovic H, Jakus N, Brugts JJ, Pouleur AC, Timmermans P, Rubiś P, et al. Impact of progressive aortic regurgitation on outcomes after left ventricular assist device implantation. Heart and Vessels. 2022; 37: 1985–1994.
Rao V, Billia F. Myocardial recovery following durable left ventricular assist device support. JTCVS Open. 2021; 8: 1–5.
Birks EJ, Drakos SG, Patel SR, Lowes BD, Selzman CH, Starling RC, et al. Prospective Multicenter Study of Myocardial Recovery Using Left Ventricular Assist Devices (RESTAGE-HF [Remission from Stage D Heart Failure]): Medium-Term and Primary End Point Results. Circulation. 2020; 142: 2016–2028.
Published
How to Cite
Issue
Section
Copyright (c) 2024 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
